Jubilant Pharmova
BSE: 530019 | NSE: JUBLPHARMA | ISIN: INE700A01033 | SECTOR: Biotechnology & DrugsRatios
- Management Effectiveness
- Margins
- Financial Strength
- Valuation
- Income Statement
- Growth
- Per Share Data
- Price and Volume
Return on average equity - 5 year average
8.36Net Income/employee - trailing 12 month
3,28,713.70Revenue/employee - most recent fiscal year
11,69,78,200.00Return on investment - most recent fiscal year
-0.73Return on average assets - most recent fiscal year
-0.61Receivables turnover - most recent fiscal year
6.15Return on investment - trailing 12 month
-Return on average assets - trailing 12 month
-Inventory turnover - most recent fiscal year
1.64Inventory turnover - trailing 12 month
-Revenue/employee - trailing 12 month
6,40,45,440.00Return on average assets - 5 year average
3.95Net Income/employee - most recent fiscal year
-12,08,212.00Return on average equity - trailing 12 month
-Receivables turnover - trailing 12 month
-Asset turnover - most recent fiscal year
0.59Asset turnover - trailing 12 month
-Return on average equity - most recent fiscal year
-1.14Return on investment - 5 year average
4.78